1 active trials 0 recruiting 1 disease areas 1 changes in 30 days
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06048133 | Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced… | Biliary Tract Carcinoma | Active, Not Recruiting | 2026-08-17 |